| Stage | RNG | % of rev | DBD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $676M | 100.00% | $994M | 100.00% | DBD ×1.47 |
| Gross profit | $494M | 73.12% | $247M | 24.86% | RNG +48.3pp |
| Operating income | $54M | 7.97% | $39M | 3.90% | RNG +4.1pp |
| Pre-tax income | $28M | 4.14% | $15M | 1.54% | RNG +2.6pp |
| Net income | $570M | 84.27% | $7M | 0.71% | RNG +83.6pp |
| Stage | RNG | DBD | Gap · A − B |
|---|---|---|---|
| Revenue | $676M100.00% | $994M100.00% | DBD ×1.47 |
| Gross profit | 73.12%$494M | 24.86%$247M | RNG +48.3pp |
| Operating income | 7.97%$54M | 3.90%$39M | RNG +4.1pp |
| Pre-tax income | 4.14%$28M | 1.54%$15M | RNG +2.6pp |
| Net income |
| 84.27%$570M |
| 0.71%$7M |
| RNG +83.6pp |